Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding

NCT00152399 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Peptic Ulcer

Interventions

DRUG: Somatostatin UCB (drug)

Sponsor

UCB Pharma